ProShare Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.77M | Sell |
7,788
-50
| -0.6% | -$8.9K | ﹤0.01% | 701 |
|
|
2026
Q1 | $1.35M | Sell |
7,838
-2,918
| -27% | -$541K | ﹤0.01% | 737 |
|
|
2025
Q4 | $2.15M | Sell |
10,756
-2,397
| -18% | -$435K | ﹤0.01% | 689 |
|
|
2025
Q3 | $2.06M | Buy |
13,153
+4,386
| +50% | +$697K | ﹤0.01% | 693 |
|
|
2025
Q2 | $1.33M | Buy |
8,767
+653
| +8% | +$87.1K | ﹤0.01% | 739 |
|
|
2025
Q1 | $1.22M | Sell |
8,114
-5,425
| -40% | -$910K | ﹤0.01% | 759 |
|
|
2024
Q4 | $2.5M | Sell |
13,539
-24
| -0.2% | -$4.62K | 0.01% | 653 |
|
|
2024
Q3 | $2.67M | Buy |
13,563
+3,588
| +36% | +$746K | 0.01% | 634 |
|
|
2024
Q2 | $2.06M | Buy |
9,975
+583
| +6% | +$132K | 0.01% | 665 |
|
|
2024
Q1 | $2.54M | Sell |
9,392
-2,105
| -18% | -$503K | 0.01% | 633 |
|
|
2023
Q4 | $2.72M | Sell |
11,497
-597
| -5% | -$117K | 0.01% | 606 |
|
|
2023
Q3 | $2.37M | Sell |
12,094
-746
| -6% | -$153K | 0.01% | 623 |
|
|
2023
Q2 | $2.7M | Buy |
12,840
+1,731
| +16% | +$344K | 0.01% | 622 |
|
|
2023
Q1 | $2.24M | Buy |
11,109
+3,470
| +45% | +$786K | 0.01% | 643 |
|
|
2022
Q4 | $1.66M | Buy |
7,639
+733
| +11% | +$160K | 0.01% | 649 |
|
|
2022
Q3 | $1.36M | Sell |
6,906
-811
| -11% | -$175K | 0.01% | 681 |
|
|
2022
Q2 | $1.65M | Sell |
7,717
-2,948
| -28% | -$720K | 0.01% | 676 |
|
|
2022
Q1 | $3.03M | Sell |
10,665
-303
| -3% | -$93.4K | 0.01% | 638 |
|
|
2021
Q4 | $4.13M | Buy |
10,968
+2,481
| +29% | +$964K | 0.01% | 611 |
|
|
2021
Q3 | $3.5M | Sell |
8,487
-172
| -2% | -$71.4K | 0.01% | 587 |
|
|
2021
Q2 | $3.2M | Buy |
8,659
+3,893
| +82% | +$1.3M | 0.01% | 604 |
|
|
2021
Q1 | $1.38M | Sell |
4,766
-29
| -0.6% | -$8.06K | ﹤0.01% | 832 |
|
|
2020
Q4 | $1.2M | Buy |
4,795
+580
| +14% | +$138K | ﹤0.01% | 801 |
|
|
2020
Q3 | $954K | Buy |
4,215
+136
| +3% | +$28.2K | ﹤0.01% | 733 |
|
|
2020
Q2 | $711K | Buy |
4,079
+1,391
| +52% | +$222K | ﹤0.01% | 804 |
|
|
2020
Q1 | $339K | Sell |
2,688
-2,624
| -49% | -$394K | ﹤0.01% | 842 |
|
|
2019
Q4 | $811K | Buy |
5,312
+487
| +10% | +$67.4K | ﹤0.01% | 870 |
|
|
2019
Q3 | $639K | Sell |
4,825
-240
| -5% | -$32.2K | ﹤0.01% | 900 |
|
|
2019
Q2 | $719K | Sell |
5,065
-861
| -15% | -$117K | ﹤0.01% | 883 |
|
|
2019
Q1 | $861K | Buy |
5,926
+1,321
| +29% | +$174K | 0.01% | 832 |
|
|
2018
Q4 | $521K | Sell |
4,605
-1,057
| -19% | -$132K | ﹤0.01% | 932 |
|
|
2018
Q3 | $762K | Buy |
5,662
+443
| +8% | +$54.7K | 0.01% | 939 |
|
|
2018
Q2 | $586K | Buy |
5,219
+5
| +0.1% | +$541 | ﹤0.01% | 1042 |
|
|
2018
Q1 | $557K | Sell |
5,214
-153
| -3% | -$16.5K | ﹤0.01% | 1058 |
|
|
2017
Q4 | $587K | Buy |
5,367
+1,201
| +29% | +$131K | ﹤0.01% | 1051 |
|
|
2017
Q3 | $450K | Sell |
4,166
-121
| -3% | -$12.4K | ﹤0.01% | 1000 |
|
|
2017
Q2 | $434K | Sell |
4,287
-642
| -13% | -$59.1K | ﹤0.01% | 1007 |
|
|
2017
Q1 | $443K | Sell |
4,929
-297
| -6% | -$25.2K | ﹤0.01% | 1047 |
|
|
2016
Q4 | $398K | Buy |
5,226
+857
| +20% | +$65.1K | ﹤0.01% | 1200 |
|
|
2016
Q3 | $364K | Sell |
4,369
-1,100
| -20% | -$92.2K | 0.01% | 1078 |
|
|
2016
Q2 | $451K | Buy |
5,469
+9
| +0.2% | +$741 | 0.01% | 1019 |
|
|
2016
Q1 | $415K | Sell |
5,460
-583
| -10% | -$43.2K | 0.01% | 1076 |
|
|
2015
Q4 | $486K | Buy |
6,043
+561
| +10% | +$40.5K | 0.01% | 1041 |
|
|
2015
Q3 | $348K | Sell |
5,482
-3,059
| -36% | -$220K | ﹤0.01% | 1082 |
|
|
2015
Q2 | $601K | Sell |
8,541
-276
| -3% | -$20.4K | 0.01% | 1016 |
|
|
2015
Q1 | $699K | Sell |
8,817
-1,014
| -10% | -$74.8K | 0.01% | 1023 |
|
|
2014
Q4 | $626K | Sell |
9,831
-15,441
| -61% | -$968K | 0.01% | 1101 |
|
|
2014
Q3 | $1.51M | Buy |
25,272
+1,716
| +7% | +$98.2K | 0.02% | 876 |
|
|
2014
Q2 | $1.26M | Buy |
23,556
+17,247
| +273% | +$946K | 0.02% | 1049 |
|
|
2014
Q1 | $381K | Sell |
6,309
-29,620
| -82% | -$1.73M | ﹤0.01% | 2076 |
|
|
2013
Q4 | $1.91M | Buy |
35,929
+30,317
| +540% | +$1.52M | 0.03% | 755 |
|
|
2013
Q3 | $260K | Buy |
+5,612
| New | +$258K | 0.01% | 1999 |
|
Other funds holding CRL
AI
ProShare Advisors's CRL Position: Q2 2026 in Review
ProShare Advisors reduced its Charles River Laboratories (CRL) stake by 0.64% in Q2 2026, selling an estimated $8.9K and leaving 7,788 shares worth $1.77M. The position accounts for ﹤0.01% of the portfolio, ranked #701.
ProShare Advisors first reported a position in CRL in Q3 2013 and has held it in 52 quarters since. The position peaked at $4.13M in Q4 2021. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- ProShare Advisors held 7,788 shares of Charles River Laboratories worth $1.77M as of Q2 2026.
- ProShare Advisors sold 50 Charles River Laboratories shares in Q2 2026, an estimated $8.9K.
- Charles River Laboratories made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #701 holding.
- ProShare Advisors first reported a position in Charles River Laboratories in Q3 2013 and has held it in 52 quarters since.
- ProShare Advisors's Charles River Laboratories position peaked at $4.13M in Q4 2021.
- 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.